Provided by Tiger Fintech (Singapore) Pte. Ltd.

Veru Inc.

0.4890
-0.0243-4.73%
Volume:1.05M
Turnover:524.61K
Market Cap:71.58M
PE:-1.86
High:0.5281
Open:0.5201
Low:0.4851
Close:0.5133
Loading ...

Nasdaq Dips 3%; Chicago Fed National Activity Index Rises In December

Benzinga
·
27 Jan

Veru's Enobosarm Meets Primary Endpoint of Preserving Lean Body Mass in Phase 2b Study

MT Newswires Live
·
27 Jan

Veru's experimental drug helps older obese patients on Wegovy preserve muscle

Reuters
·
27 Jan

Veru's muscle preserving drug meets main goal in mid-stage study

Reuters
·
27 Jan

Veru Inc: Study Met Primary Endpoint

THOMSON REUTERS
·
27 Jan

Veru Announces Positive Topline Data From Phase 2B Quality Clinical Study: Enobosarm Preserved Lean Mass in Patients Receiving Wegovy® (Semaglutide) for Weight Reduction

THOMSON REUTERS
·
27 Jan

Veru Inc - Enobosarm Treatment Significantly Reduces Lean Mass Loss in Wegovy Patients

THOMSON REUTERS
·
27 Jan

Veru: Patients on Enobosarm on Average Lost 27% More Fat Mass Than Patients Receiving Wegovy Alone

THOMSON REUTERS
·
27 Jan

Veru: Enobosarm Cut Proportion of Patients That Lost Clinically Significant Physical Function VS Those on Wegovy Alone

THOMSON REUTERS
·
27 Jan

Veru Announces Positive Topline Data from Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass in Patients Receiving WEGOVY® (Semaglutide) for Weight Reduction

GlobeNewswire
·
27 Jan

What Makes Veru Inc. (VERU) a Strong Momentum Stock: Buy Now?

Zacks
·
24 Jan

Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Veru (VERU)

TIPRANKS
·
12 Jan

Veru Inc. Sells FC2 Business to Focus on Biopharma

TIPRANKS
·
04 Jan

Veru Price Target Maintained With a $3.00/Share by HC Wainwright & Co.

Dow Jones
·
02 Jan

Analysts Offer Insights on Healthcare Companies: Corvus Pharmaceuticals (CRVS) and Veru (VERU)

TIPRANKS
·
02 Jan

Veru Sells FC2 Condom Business For $18 Million, Focuses On Biopharma Pipeline

Benzinga
·
01 Jan